chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pain in extremity, Pyrexia
Clinical narrative: low-grade fever; chills; headache; body aches; sore arm; This is a spontaneous report from a non-contactable consumer. A 44-years-old female patient received second of BNT162B2(Formulation: Solution for injection; Batch/Lot number), dose 2 via an unspecified route of administration, administered in Arm Right on 05Mar2021 09:00 AM as 2ND DOSE SINGLE DOSE for covid-19 immunisation. Medical history included allergy with Penicillin from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient received first dose of BNT162B2 (Formulation: Solution for injection; Batch/Lot number), dose 1 via an unspecified route of administration, administered in Arm Right on 11Feb2021 02:00 PM as 1ST DOSE SINGLE DOSE for covid-19 immunisation. Patient did not received any other vaccines within 4 weeks. On 05Mar2021 21:00 AM patient experienced low-grade fever, chills, headache, body aches, sore arm. Since the vaccination, patient has not been tested for COVID-19. The outcome of the events was recovered on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: I drove over two hours to get the vaccine.  About 1.5 hours into the drive I get a bad head rush.  I had to pull over on the freeway.; This is a spontaneous report from a contactable consumer or other non-health care professional. A 54-Year-old female non-pregnant patient started to receive first dose of bnt162b2 (BNT162B2, solution for injection, Lot Number: EN6199 and Expiration date: Unknown) via an unspecified route of administration and administered in right arm on 06Mar2021 15:00 as 1st dose, single dose for COVID-19 immunization. The patient medical history included high cholesterol. The patient's concomitant medications were not reported. There was no known allergies and did not experience Covid-19 before vaccination. The patient experienced drove over two hours to get the vaccine. About 1.5 hours into the drive the patient had a bad head rush and to pull over on the freeway on 06Mar2021 (at16:45). The patient was not tested for Covid-19 on post vaccination. The patient didn't receive any treatment as a result of event. The outcome of event was considered as recovered.  No follow-up attempts are possible. No further information is expected
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: This is a spontaneous report from a contactable other health care professional (patient). A 34-year-old non-pregnant female patient (not pregnant at the time of vaccination) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration on 02Mar2021 at 12:00 as UNKNOWN, single dose for covid-19 immunisation. The patient medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. Patient had no known allergies. Concomitant medications included citalopram (CITALOPRAM); alfetamines aspartate, amphetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) for an unspecified indication, start and stop date were not reported. The patient did not receive other vaccine in four weeks. On 03Mar2021, patient experienced small patch of rash on left upper chest. The patient did not received treatment due to the events. The outcome of events was recovered on an unspecified date in 2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling cold, Pain
Clinical narrative: Very cold and full body aches; Very cold and full body aches; This is a spontaneous report received from a contactable consumer (Patient, self-reported). A 44-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number and Expiry date: not reported), dose 2 via an unspecified route of administration, in the left arm, on 24Feb2021 at 15:30, as single dose for COVID-19 immunisation in the school or student health clinic. The patient's medical history and concomitant medications was not reported. The patient was not allergic. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number and Expiry date: not reported), dose 1 via an unspecified route of administration, in the left arm, on 03Feb2021 at 17:30, as single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medication within 2 weeks. The patient was not diagnosed with COVID-19 prior to vaccination. On 26Feb2021 09:00, the patient experienced very cold and full body aches. No treatment was received. The patient not tested for COVID-19 since the vaccination. The outcome of the events was recovered on an unknown date in 2021.  No follow-up attempts are Possible. Information on lot/batch cannot be obtained.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Myalgia, Papule, Somnolence
Clinical narrative: I had extreme muscle pain in my thigh muscles throughout the night and the next day.; Initially slight case of raised bumps on opposite arm; I feel exhausted no matter how much coffee I have had today, and it has been plenty; I woke up, ate breakfast and fell back asleep until 1:30 pm. Felt OK for two days. Can't seem to stay awake today. Woke up late, fell back asleep until 1:30 pm; This is a spontaneous report was received from a contactable consumer (patient). A 67-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in left arm on 04Mar2021 as 1st dose, single dose (at the age of 67) for covid-19 immunisation. The patient's medical history included allergy to Quinolones. Patient had not received any other vaccine prior four weeks of vaccination. Patient was not diagnosed with covid-19 prior to vaccination. Concomitant medications included mirtazapine (MIRTAZAPINE), oxcarbazepine (TRILEPTAL), lamotrigine (LAMOTRIGINE), diazepam (DIAZEPAM) and zol (as reported) taken for an unspecified indication. On 04Mar2021 at 22:45, the patient had experienced initially slight case of raised bumps on opposite arm and had extreme muscle pain in my thigh muscles throughout the night and the next day, woke up, ate breakfast and fell back asleep until 1:30 pm. The patient felt okay for two days and could not seem to stay awake today. Woke up late, fell back asleep until 1:30 pm. The patient felt exhausted no matter how much coffee she had today, and it has been plenty. Since vaccination patient not tested for covid-19. Patient has not received any treatment for the events. The outcome of the events was unknown.  No follow up attempts are possible. Information about lot/batch number cannot been obtained.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Myalgia, Papule, Somnolence
Clinical narrative: Initially slight case of raised bumps on opposite arm; I had extreme muscle pain in my thigh muscles throughout the night and the next day; I feel exhausted no matter how much coffee I have had today and it has been plenty; I woke up, ate breakfast and fell back asleep unti 1:30 pm. Felt OK for two days. Can't seem to stay awake today. Woke up late, fell back asleep until 1:30 pm; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection), via an unspecified route of administration in left arm on 04Mar2021 as single dose for COVID-19 immunisation at Pharmacy or Drug Store. The patient medical history was not reported. Patient was not pregnant at the time of vaccination. Concomitant medications in two weeks included mirtazapine; oxcarbazepine (TRILEPTAL); lamotrigine; diazepam; zoledronic acid. Patient previously took quinolones and had allergies. The patient did not receive any other vaccine in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. On 04Mar2021 at 10:45 PM, patient experienced initially slight case of raised bumps on opposite arm. She had extreme muscle pain in thigh muscles throughout the night and the next day. She woke up, ate breakfast and fell back asleep until 1:30 pm. Felt OK for two days. Can't seem to stay awake today. Woke up late, fell back asleep until 1:30 pm. She felt exhausted no matter how much coffee she have had today and it has been plenty. The patient did not receive treatment due to the events. The outcome of events was unknown.  No follow up attempts are possible. Information about lot/batch number cannot been obtained
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Arthralgia, Chills, Diarrhoea, Pelvic pain
Clinical narrative: intense diarrhea every 15-30 minutes x 3 days; moderate abdominal, pelvic and rectal pain x 3 days (gradually decreasing on 3rd day); Moderate pain in joints of hips and knees x 1.5 days.; moderate abdominal, pelvic and rectal pain x 3 days (gradually decreasing on 3rd day); moderate abdominal, pelvic and rectal pain x 3 days (gradually decreasing on 3rd day); fever and chills overnight x 1 day; severe pain at injection site x 24 hrs; fever and chills overnight x 1 day; This is a spontaneous report from a contactable consumer or other non-health care professional. A 70-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6206), via an unspecified route of administration, administered in Arm Right on 04Mar2021 11:00 as 1st dose, single dose for COVID-19 immunization. Medical history included hypertension, depression, MGUS, prediabetes, neuropathy, anxiety/panic disorder, hypothyroidism from an unknown date and unknown if ongoing. Concomitant medications included cozaar, lipitor, buspar, gabapentin, trazadone, sy taken for an unspecified indication, start and stop date were not reported.  The patient did not receive any other vaccine in four weeks. The patient was not had Covid prior vaccination, and the test was not performed post vaccination. The patient experienced severe pain at injection site x 24 hrs , fever and chills overnight x 1 day, intense diarrhea every 15-30 minutes x 3 days , moderate abdominal, pelvic and rectal pain x 3 days, moderate pain in joints of hips and knees x 1.5 days on 04Mar2021 21:00. The events were assessed as non-serious. The treatment was received for all the events with pepto bismol self-administered. The outcome of the events was reported as recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Proctalgia, Pyrexia, Vaccination site pain
Clinical narrative: intense diarrhea every 15-30 minutes x 3 days; moderate abdominal, pelvic and rectal pain x 3 days (gradually decreasing on 3rd day); Moderate pain in joints of hips and knees x 1.5 days.; moderate abdominal, pelvic and rectal pain x 3 days (gradually decreasing on 3rd day); moderate abdominal, pelvic and rectal pain x 3 days (gradually decreasing on 3rd day); fever and chills overnight x 1 day; severe pain at injection site x 24 hrs; fever and chills overnight x 1 day; This is a spontaneous report from a contactable consumer or other non-health care professional. A 70-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6206), via an unspecified route of administration, administered in Arm Right on 04Mar2021 11:00 as 1st dose, single dose for COVID-19 immunization. Medical history included hypertension, depression, MGUS, prediabetes, neuropathy, anxiety/panic disorder, hypothyroidism from an unknown date and unknown if ongoing. Concomitant medications included cozaar, lipitor, buspar, gabapentin, trazadone, sy taken for an unspecified indication, start and stop date were not reported.  The patient did not receive any other vaccine in four weeks. The patient was not had Covid prior vaccination, and the test was not performed post vaccination. The patient experienced severe pain at injection site x 24 hrs , fever and chills overnight x 1 day, intense diarrhea every 15-30 minutes x 3 days , moderate abdominal, pelvic and rectal pain x 3 days, moderate pain in joints of hips and knees x 1.5 days on 04Mar2021 21:00. The events were assessed as non-serious. The treatment was received for all the events with pepto bismol self-administered. The outcome of the events was reported as recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal discomfort, Pruritus, Urticaria
Clinical narrative: severe hives/hives measured about 2 inches thick and 6 inches long in some places on my body/I just had hives that were itchy; severe hives/hives measured about 2 inches thick and 6 inches long in some places on my body/I just had hives that were itchy; My throat did not close; This is a spontaneous report received from a contactable consumer or other non hcp. A 26-years-old non pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Batch/Lot number: EM9809; Expiry date: unknown), via an unspecified route of administration in the left arm on 06Feb2021 13:00 (age at vaccination 26 years old) as a single dose for COVID-19 immunization. The patient medical history was not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient received other mediations in two weeks. Concomitant medication(s) included ethinylestradiol, norethisterone acetate (JUNEL) and amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) 15xr taken for an unspecified indication, start and stop date were not reported. The patient did not have COVID prior to vaccination. On 09Feb2021 12:00pm the patient experienced severe hives 3 days after getting the shot. The patient did not have sensitive skin and had never broken out in hives like she did. The hives measured about 2 inches thick and 6 inches long in some places on her body. The patient throat did not close, and she didn't have any trouble breathing, she just had hives that were itchy. No treatment was received for the events. No covid tested post vaccination. The clinical outcome of the events was recovered.  No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Small red bump the size of a dime and soreness/ injection bump; Small red bump the size of a dime and soreness; Injection bump about the size of a quarter, and red; Swollen around the injection site to about 4 inches in diameter; Swollen around the injection site to about 4 inches in diameter and itchy and warm; Swollen around the injection site to about 4 inches in diameter and itchy and warm; This is a spontaneous report from a contactable Consumer. This 59-year-old female Consumer (patient) reported (for herself). A 59-years-old non pregnant female patient (patient was not pregnant at the time of vaccination) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number was not reported) via an unspecified route of administration in left arm on 06Mar2021 at 14:45 (at the age of b59-year-old) as a single dose for covid-19 immunization. Medical history included primary progressive aphasia, allergy to shellfish and bee sting all from an unknown date and unknown if ongoing. The patient previously took erythromycin and experienced allergy. The patient did not received any other vaccine in four weeks or any other medications in two weeks. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number was not reported) on 13Feb2021 at 14:45 in left arm for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient had not been tested for COVID-19. On 06Mar2021 at 16:30, the patient reported that after few hours of the vaccine shot she had a small red bump which was the size of a dime and had soreness. The injection bump was about the size of a quarter and red. It was swollen around the injection site to about 4 inches in diameter and also it was itchy and warm. The patient did not received any treatment. The outcome of all events were not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Small red bump the size of a dime and soreness/ injection bump; Small red bump the size of a dime and soreness; Injection bump about the size of a quarter, and red; Swollen around the injection site to about 4 inches in diameter; Swollen around the injection site to about 4 inches in diameter and itchy and warm; Swollen around the injection site to about 4 inches in diameter and itchy and warm; This is a spontaneous report from a contactable Consumer. This 59-year-old female Consumer (patient) reported (for herself). A 59-years-old non pregnant female patient (patient was not pregnant at the time of vaccination) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number was not reported) via an unspecified route of administration in left arm on 06Mar2021 at 14:45 (at the age of b59-year-old) as a single dose for covid-19 immunization. Medical history included primary progressive aphasia, allergy to shellfish and bee sting all from an unknown date and unknown if ongoing. The patient previously took erythromycin and experienced allergy. The patient did not received any other vaccine in four weeks or any other medications in two weeks. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number was not reported) on 13Feb2021 at 14:45 in left arm for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient had not been tested for COVID-19. On 06Mar2021 at 16:30, the patient reported that after few hours of the vaccine shot she had a small red bump which was the size of a dime and had soreness. The injection bump was about the size of a quarter and red. It was swollen around the injection site to about 4 inches in diameter and also it was itchy and warm. The patient did not received any treatment. The outcome of all events were not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Sore shoulder woke up with pain; This is a spontaneous report from a contactable consumer (patient).    A 57-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, Batch/Lot Number: EN6119, expiration date unknown) 1st dose, via an unspecified route of administration administered in Arm Right on 06Mar2021 15:45 pm, (at the age of 57-years-old) as first dose single dose for covid-19 immunization. Medical history included hypothyroidism. Patient had no known allergies. patient had not Covid prior vaccination and not Covid tested post vaccination. patient did not received any other vaccine in four weeks. Concomitant medication included levothyroxine taken for an unspecified indication, start and stop date were not reported. On 07Mar2021 04:00 am patient experienced sore shoulder woke up with pain. The outcome of the event was recovering.    No follow-up attempts are possible; no further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dyspnoea, Fatigue, Headache
Clinical narrative: Headache; fever; cold chills; body aches; arm pain; allergic reaction; diarrhea; fatigue; swollen lymph nodes; irritability; really swollen underarm with extreme pain on injection site arm that still has not resolved; really swollen underarm with extreme pain on injection site arm that still has not resolved; rash; difficulty breathing; This is a spontaneous report from a contactable consumer. This 34-year-old non-pregnant caucasian female consumer (patient) reported for herself that she received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on 04Mar2021 at 04: 30 PM on left arm as 2nd dose, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The Historical vaccine of the patient included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on 11Feb2021 at 06:16 PM on left arm as 1st dose, single dose for COVID-19 immunization. It was reported that the patient did not receive any other vaccine in four weeks, she did not have covid prior vaccination and was not tested for covid post vaccination. On 04Mar2021 at 04:45 PM, the same day, fifteen minutes later the patient experienced headache, fever, cold chills, body aches, arm pain, allergic reaction, diarrhea, fatigue, swollen lymph nodes, irritability, really swollen underarm with extreme pain on injection site arm that still has not resolved, rash, difficulty breathing. It was unknown if patient received any treatment. The outcome of events was not recovered.   No follow-up attempts were possible. No further information was expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Injection site pain, Irritability, Lymphadenopathy, Pain
Clinical narrative: Headache; fever; cold chills; body aches; arm pain; allergic reaction; diarrhea; fatigue; swollen lymph nodes; irritability; really swollen underarm with extreme pain on injection site arm that still has not resolved; really swollen underarm with extreme pain on injection site arm that still has not resolved; rash; difficulty breathing; This is a spontaneous report from a contactable consumer. This 34-year-old non-pregnant caucasian female consumer (patient) reported for herself that she received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on 04Mar2021 at 04: 30 PM on left arm as 2nd dose, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The Historical vaccine of the patient included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on 11Feb2021 at 06:16 PM on left arm as 1st dose, single dose for COVID-19 immunization. It was reported that the patient did not receive any other vaccine in four weeks, she did not have covid prior vaccination and was not tested for covid post vaccination. On 04Mar2021 at 04:45 PM, the same day, fifteen minutes later the patient experienced headache, fever, cold chills, body aches, arm pain, allergic reaction, diarrhea, fatigue, swollen lymph nodes, irritability, really swollen underarm with extreme pain on injection site arm that still has not resolved, rash, difficulty breathing. It was unknown if patient received any treatment. The outcome of events was not recovered.   No follow-up attempts were possible. No further information was expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Pyrexia, Rash
Clinical narrative: Headache; fever; cold chills; body aches; arm pain; allergic reaction; diarrhea; fatigue; swollen lymph nodes; irritability; really swollen underarm with extreme pain on injection site arm that still has not resolved; really swollen underarm with extreme pain on injection site arm that still has not resolved; rash; difficulty breathing; This is a spontaneous report from a contactable consumer. This 34-year-old non-pregnant caucasian female consumer (patient) reported for herself that she received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on 04Mar2021 at 04: 30 PM on left arm as 2nd dose, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The Historical vaccine of the patient included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on 11Feb2021 at 06:16 PM on left arm as 1st dose, single dose for COVID-19 immunization. It was reported that the patient did not receive any other vaccine in four weeks, she did not have covid prior vaccination and was not tested for covid post vaccination. On 04Mar2021 at 04:45 PM, the same day, fifteen minutes later the patient experienced headache, fever, cold chills, body aches, arm pain, allergic reaction, diarrhea, fatigue, swollen lymph nodes, irritability, really swollen underarm with extreme pain on injection site arm that still has not resolved, rash, difficulty breathing. It was unknown if patient received any treatment. The outcome of events was not recovered.   No follow-up attempts were possible. No further information was expected.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pain, Pyrexia
Clinical narrative: body aches; Fever of 101.8; This is a spontaneous report from a contactable consumer (patient). A 23-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported), via an unspecified route of administration on 04Mar2021 as second dose, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 05Mar2021 morning the patient experienced little body aches then later in the day she started to have a fever. She said an hour before reporting it went up a whole degree and she is getting really hot. She said when she went to get the vaccine, the nurse who gave her the vaccine told her she couldn't have Ibuprofen, and then on info sheet it said she could. With a fever of 101.8, she wants to know if she can take some because she wants to. The outcome of the event fever was not recovered, while the outcome of  the event little body aches was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Mobility decreased, Musculoskeletal stiffness, Neck pain
Clinical narrative: Stiffness and soreness on her left arm and up to her neck.; Vaccination site is extremely painful; Mld soreness in her arm; Couldnt raise my left arm above my head/ she cant raise her left arm today without slightly raising her right arm; I have been extremely tired/ Shes very tired; Five days after vaccine, I experienced severe pain in my left shoulder and neck constantly; Five days after vaccine, I experienced severe pain in my left shoulder and neck constantly.; This is a spontaneous report from a contactable consumer (patient).  A 58-years-old female patient receivedBNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 25Feb2021 12:45 (Batch/Lot Number: EN6205) age at vaccination of 58-years-old, as single dose, for covid-19 immunisation. Medical history included breast cancer from 2008 to an unknown date, hypertension from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing (known_allergies Penicillin). The patient was not pregnant and was not pregnant at the time of vaccination. Concomitant medication included metoprolol tartrate (METOPROLOL TARTRATE) taken for an unspecified indication, start and stop date were not reported.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 02Mar2021 at 12:00 PM (five days after vaccine), the patient experienced severe pain in left shoulder and neck constantly. The patient took ibuprofen for 2 days and then took Tylenol. It didn't help much. Then on 07Mar2021 the patient woke up and couldn't raise left arm above head and was extremely tired (she is typically a very energetic person); no treatments were given for these events. The patient also reported that after vaccine (date unspecified) she had a mild soreness in her arm and a few days later had a stiffness and soreness on her left arm and up to her neck, she can't raise her left arm without slightly raising her right arm, she was very tired and vaccination site is extremely painful. Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient was not recovered from the events.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: Stiffness and soreness on her left arm and up to her neck.; Vaccination site is extremely painful; Mld soreness in her arm; Couldnt raise my left arm above my head/ she cant raise her left arm today without slightly raising her right arm; I have been extremely tired/ Shes very tired; Five days after vaccine, I experienced severe pain in my left shoulder and neck constantly; Five days after vaccine, I experienced severe pain in my left shoulder and neck constantly.; This is a spontaneous report from a contactable consumer (patient).  A 58-years-old female patient receivedBNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 25Feb2021 12:45 (Batch/Lot Number: EN6205) age at vaccination of 58-years-old, as single dose, for covid-19 immunisation. Medical history included breast cancer from 2008 to an unknown date, hypertension from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing (known_allergies Penicillin). The patient was not pregnant and was not pregnant at the time of vaccination. Concomitant medication included metoprolol tartrate (METOPROLOL TARTRATE) taken for an unspecified indication, start and stop date were not reported.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 02Mar2021 at 12:00 PM (five days after vaccine), the patient experienced severe pain in left shoulder and neck constantly. The patient took ibuprofen for 2 days and then took Tylenol. It didn't help much. Then on 07Mar2021 the patient woke up and couldn't raise left arm above head and was extremely tired (she is typically a very energetic person); no treatments were given for these events. The patient also reported that after vaccine (date unspecified) she had a mild soreness in her arm and a few days later had a stiffness and soreness on her left arm and up to her neck, she can't raise her left arm without slightly raising her right arm, she was very tired and vaccination site is extremely painful. Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient was not recovered from the events.   No follow-up attempts are needed. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness
Clinical narrative: Major Fatigue & flu-like symptoms since 4 days following injection; Major Fatigue & flu-like symptoms since 4 days following injection; This is a spontaneous report from a contactable consumer.    A 76-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 19Feb2021 12:45 (at the age of 76-year-old) as single dose for covid-19 immunisation.  Medical history included fatigue from an unknown date and unknown if ongoing. There were no concomitant medications.    The patient experienced major fatigue and flu-like symptoms on 23Feb2021 with outcome of not recovered.    No follow-up attempts are possible; information about lot/batch number cannot been obtained
Sex: M
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: Was sick; This is a spontaneous received report from a Pfizer-sponsored program, a contactable consumer (patient wife). A 71-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported, Pfizer NTEC), via an unspecified route of administration on an unspecified date as single dose and second dose via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. Medical history included covid before vaccine. The patient concomitant medications were not reported. It was reported patient got his vaccine and was sick for 10 days after the first dose and 24 hours after the second dose. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Fatigue, Headache, Nausea
Clinical narrative: stomachache; Headache; fatigue; nausea; This is a spontaneous report from a contactable consumer (patient).  A 53-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 05Mar2021 19:30 (Batch/Lot number was not reported) age at vaccination of 53-years-old, as single dose, for covid-19 immunisation. Medical history included migraine from an unknown date and unknown if ongoing, colon cancer from 2009 to an unknown date, drug hypersensitivity from an unknown date and unknown if ongoing (allergy to Sulfa drugs), allergy to chemicals from an unknown date and unknown if ongoing allergy to alcoholic beverages, food allergy from an unknown date and unknown if ongoing (clams). The patient was not pregnant and was not pregnant at the time of vaccination. Concomitant medications included aripiprazole (ABILIFY) taken for an unspecified indication, start and stop date were not reported; venlafaxine hydrochloride (EFFEXOR) taken for an unspecified indication, start and stop date were not reported; topiramate (TOPIRAMATE) taken for an unspecified indication, start and stop date were not reported; probiotics (PROBIOTICS) taken for an unspecified indication, start and stop date were not reported; iron (IRON) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced headache, fatigue, nausea, stomachache on 06Mar2021 08:00. No treatments were given. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Swelling of eyelid
Clinical narrative: Swollen eyelids and face; Swollen eyelids and face; This is a spontaneous report from a contactable consumer reporting for herself  A 70-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6202) on 25Feb2021 at 14:45 at single dose via an unspecified route of administration on left arm for COVID-19 immunization. The patient didn't have medical history. Concomitant medications included multivitamin, ascorbic acid (VITAMIN C) and calcium. The patient received first dose of BNT162B2 on 04Feb2021 at 14:45 on left arm. On 04Mar2021 at 06:00 am the patient experienced swollen eyelids and face. At the time of the reporting the patient had not yet recovered from the events.   No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Pyrexia
Clinical narrative: joint pain; fever; headache; chills; This is a spontaneous report from a contactable consumer (patient)   A 66-year-old male consumer received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) on 06Mar2021  at single dose via an unspecified route of administration on left arm for COVID-19 immunization. Relevant medical history included Prostatomegaly. Concomitant medications included tamsulosin hydrochloride (FLOMAX [TAMSULOSIN HYDROCHLORIDE]). The patient received first dose of BNT162B2 on 10Feb2021 at 11:30 on left arm. On 06Mar2021 at 23:00 the patient experienced joint pain, fever, headache and chills.  No treatment was received. The patient recovered from the events on an unspecified date.   No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain
Clinical narrative: Chills; headache; very achy; Fatigue; This is a spontaneous report received from a contactable consumer (Patient herself). A 68-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration in Arm Left on 04Mar2021 13:00 as unknown, single dose for COVID-19 immunization. Medical history included Restless leg syndrome, COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. Since the vaccination, the patient was not received any treatment and patient had not been tested for COVID-19 as well. Concomitant medication included calcium, colecalciferol (D3), magnesium, macrogol 3350 (MIRALAX) and Multi vitamin. On 05Mar2021 12:00 the patient stated that she experienced some of the same symptoms as when she had the virus in August, Chills, headache, very achy and fatigue. The patient did not receive any treatment for events. On an unspecified date in 2021, the patient had recovered from the events.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Asthenia, Cough, Decreased appetite
Clinical narrative: still lacking normal energy; stomach pain; nausea; loss of appetite; extreme exhaustion; Dry cough; Injection site still somewhat tender; extreme pain in whole length of arm; joint pain; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) via an unspecified route of administration, administered in left arm on 16Feb2021 as single dose for COVID-19 immunisation. Medical history included covid-19 (November). Patient was not pregnant at time of vaccination. Patient had not received any other vaccines within 4 weeks. Patient had received other medications within 2 weeks. The patient previously took terfenadine (SELDANE) and experienced allergies. Prior to vaccination, patient was diagnosed with COVID-19. Post vaccination, the patient was not tested for COVID-19. It was reported that Day One on 16Feb2021 patient had extreme pain in whole length of arm and joint pain that woke me numerous times during the night. Day Two on 17Feb2021 extreme pain in the whole length of arm, joint pain, stomach pain, nausea, loss of appetite, extreme exhaustion often requiring returning to bed within 30 min. of getting up, infrequent dry cough that happened once--5 coughs in succession (symptoms mirrored symptoms that I had when I had Covid in November). Day 3: repeat of day 2. Day 4 on 19Feb2021 Arm pain lessened, no fever, still lacking normal energy. Was able to eat extremely small meals. Did too much, which caused arm pain to return. Day 6: Symptoms gone, except unusual fatigue. Injection site still somewhat tender on 16Feb2021 to the touch on 07Mar2021. No treatment received for events. The outcome of events extreme exhaustion, injection site pain was not recovered, while remaining events were recovered on an unspecified date in 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Pain in extremity, Vaccination site pain
Clinical narrative: still lacking normal energy; stomach pain; nausea; loss of appetite; extreme exhaustion; Dry cough; Injection site still somewhat tender; extreme pain in whole length of arm; joint pain; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) via an unspecified route of administration, administered in left arm on 16Feb2021 as single dose for COVID-19 immunisation. Medical history included covid-19 (November). Patient was not pregnant at time of vaccination. Patient had not received any other vaccines within 4 weeks. Patient had received other medications within 2 weeks. The patient previously took terfenadine (SELDANE) and experienced allergies. Prior to vaccination, patient was diagnosed with COVID-19. Post vaccination, the patient was not tested for COVID-19. It was reported that Day One on 16Feb2021 patient had extreme pain in whole length of arm and joint pain that woke me numerous times during the night. Day Two on 17Feb2021 extreme pain in the whole length of arm, joint pain, stomach pain, nausea, loss of appetite, extreme exhaustion often requiring returning to bed within 30 min. of getting up, infrequent dry cough that happened once--5 coughs in succession (symptoms mirrored symptoms that I had when I had Covid in November). Day 3: repeat of day 2. Day 4 on 19Feb2021 Arm pain lessened, no fever, still lacking normal energy. Was able to eat extremely small meals. Did too much, which caused arm pain to return. Day 6: Symptoms gone, except unusual fatigue. Injection site still somewhat tender on 16Feb2021 to the touch on 07Mar2021. No treatment received for events. The outcome of events extreme exhaustion, injection site pain was not recovered, while remaining events were recovered on an unspecified date in 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Heart rate, Heart rate increased, Pruritus, Throat tightness
Clinical narrative: Immediate itching of left arm; tightness of throat; difficulty swallowing; heart beating fast; This is a spontaneous report from a non-contactable consumer (patient herself). A 53-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EN6202), via an unspecified route of administration, administered in left arm on 05Mar2021 at 18:30 (age at vaccination: 53 years) as a SINGLE DOSE for COVID-19 immunisation. The patient's medical history included asthma, pancreatitis, Kidney Stones, penicillin allergy and sesame oil allergy. Concomitant medications included pancreatin (CREON) and omeprazole (ZEGERID) and multi-vitamin. Patient previously took tetracycline, codeine, morphine, nitrofurantoin (MACROBID), and ciprofloxacin (CIPRO); had allergy with all these medications. The patient did not receive any other medications within four weeks of vaccination. On 05Mar2021 at 18:30, the patient experienced immediate itching of left arm, tightness of throat, difficulty swallowing and heart beating fast. The patient self-administered Benadryl for the treatment of the adverse events. The patient visited the physician's office for the adverse events. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Dysphagia, Musculoskeletal stiffness, Nasal congestion, Pyrexia
Clinical narrative: Stiff neck; Swallowing difficulties; Fever symptoms; Stuffed nose; This is a spontaneous report from a contactable consumer (Patient). A 75-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration, administered in left arm on 26Feb2021 at 12:30 (at the age of 75-year-old, Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient medical history included no chronic health conditions. No known allergies were reported. Concomitant medication included within 2 weeks prior to the Covid-19 vaccine was atorvastatin (ATORVASTATIN) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the Covid-19 vaccine. The patient did not have Covid-19 prior to vaccination. The patient had not been tested for Covid-19 since the vaccination. On 01Mar2021 at 09:00, the patient experienced stiff neck, swallowing difficulties, fever symptoms and stuffed nose. AE resulted in emergency room/department or urgent care visit. The treatment for events was reported as 'left and right arms shots, two Tylenol tablets'. The outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Neck mass
Clinical narrative: two lumps that have appeared in my neck/on the left anterior and is the size of a large blueberry or small grape/on the right anterior and is the size of a pea; This is a spontaneous report from a contactable consumer reporting for herself   A 50-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3247) on 25Feb2021 at 11:15 at single dose via an unspecified route of administration on left arm for COVID-19 immunization. The patient had not medical history. Concomitant medications were not reported. On 06Mar2021 at 12:30 pm the patient noticed two lumps that have appeared in my neck. One is on the left anterior and is the size of a large blueberry or small grape. The other is on the right anterior and is the size of a pea.  Patient sawher primary care physician and she has ordered a CT scan to be performed and told patient that this could be potentially COVID vaccine- related. The patient received unspecified treatment. At the time of the reporting the patient had not yet recovered from the event.   No follow-up attempts are possible. No further information is expected.